Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421

Company Overview - Sana Biotechnology, Inc. (NASDAQ: SANA) is a biotechnology company focused on producing engineered cells to repair or replace damaged cells that cause diseases [1] - The company explores both ex vivo and in vivo approaches to develop new therapies [1] Technology and Research - For ex vivo applications, Sana leverages its proprietary technology [1]